Aptorum Group Limited (APM)
NASDAQ: APM
· Real-Time Price · USD
0.92
-0.02 (-2.02%)
At close: May 01, 2025, 3:58 PM
0.92
0.00%
After-hours: May 01, 2025, 04:00 PM EDT
-2.02% (1D)
| Bid | 0.91 |
| Market Cap | 6.57M |
| Revenue (ttm) | 431.38K |
| Net Income (ttm) | -5.47M |
| EPS (ttm) | 0.31 |
| PE Ratio (ttm) | 2.97 |
| Forward PE | 0.3 |
| Analyst | n/a |
| Ask | 1.01 |
| Volume | 15,747 |
| Avg. Volume (20D) | 99,278 |
| Open | 0.91 |
| Previous Close | 0.94 |
| Day's Range | 0.90 - 0.93 |
| 52-Week Range | 0.46 - 7.49 |
| Beta | -0.38 |
About APM
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphyloc...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 18, 2018
Employees 3
Stock Exchange NASDAQ
Ticker Symbol APM
Website https://www.aptorumgroup.com
2 weeks ago
-15.28%
Aptorum Group shares are trading lower after the c...
Unlock content with
Pro Subscription
